Oppenheimer & Co’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,342
| Closed | -$144K | – | 1603 |
|
|
2024
Q3 | $144K | Sell |
15,342
-566
| -4% | -$5.32K | ﹤0.01% | 1437 |
|
|
2024
Q2 | $128K | Sell |
15,908
-717
| -4% | -$5.75K | ﹤0.01% | 1375 |
|
|
2024
Q1 | $246K | Buy |
+16,625
| New | +$246K | ﹤0.01% | 1252 |
|
|
2022
Q2 | – | Sell |
-10,196
| Closed | -$170K | – | 1475 |
|
|
2022
Q1 | $170K | Sell |
10,196
-1,671
| -14% | -$27.9K | ﹤0.01% | 1378 |
|
|
2021
Q4 | $227K | Sell |
11,867
-3,587
| -23% | -$68.6K | ﹤0.01% | 1346 |
|
|
2021
Q3 | $381K | Buy |
15,454
+115
| +0.7% | +$2.84K | 0.01% | 1125 |
|
|
2021
Q2 | $399K | Sell |
15,339
-1,348
| -8% | -$35.1K | 0.01% | 1117 |
|
|
2021
Q1 | $528K | Sell |
16,687
-2,389
| -13% | -$75.6K | 0.01% | 943 |
|
|
2020
Q4 | $885K | Sell |
19,076
-4,690
| -20% | -$218K | 0.02% | 689 |
|
|
2020
Q3 | $783K | Buy |
23,766
+3,744
| +19% | +$123K | 0.02% | 668 |
|
|
2020
Q2 | $549K | Buy |
+20,022
| New | +$549K | 0.01% | 774 |
|